BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17214747)

  • 21. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
    Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells.
    Tan G; Heqing L; Jiangbo C; Ming J; Yanhong M; Xianghe L; Hong S; Li G
    Int J Cancer; 2002 Jan; 97(2):168-72. PubMed ID: 11774260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The helix-loop-helix Id-1 inhibits PSA expression in prostate cancer cells.
    Zielinski AJ; Fong S; Allison J; Kawahara M; Coppe JP; Feiler H; Lee NM; Desprez PY
    Int J Cancer; 2010 May; 126(10):2490-6. PubMed ID: 19662653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells.
    Yasmeen A; Bismar TA; Kandouz M; Foulkes WD; Desprez PY; Al Moustafa AE
    Cell Cycle; 2007 Aug; 6(16):2038-42. PubMed ID: 17721085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells.
    Chen Y; Feng F; Gao X; Wang C; Sun H; Zhang C; Zeng Z; Lu Y; An L; Qu J; Wang F; Yang Y
    Curr Cancer Drug Targets; 2015; 15(3):176-87. PubMed ID: 25714700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation.
    Gill C; Dowling C; O'Neill AJ; Watson RW
    Mol Cancer; 2009 Jun; 8():39. PubMed ID: 19549337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
    Singh M; Bhatnagar P; Mishra S; Kumar P; Shukla Y; Gupta KC
    Int J Nanomedicine; 2015; 10():6789-809. PubMed ID: 26586942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
    Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
    Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.
    Sharma P; Chinaranagari S; Chaudhary J
    Biochimie; 2015 May; 112():139-50. PubMed ID: 25778840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smac mimetic SM-164 potentiates APO2L/TRAIL- and doxorubicin-mediated anticancer activity in human hepatocellular carcinoma cells.
    Zhang S; Li G; Zhao Y; Liu G; Wang Y; Ma X; Li D; Wu Y; Lu J
    PLoS One; 2012; 7(12):e51461. PubMed ID: 23240027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple‑negative breast cancer cells.
    Lee J; Gollahon L
    Int J Oncol; 2013 Mar; 42(3):839-47. PubMed ID: 23340795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein.
    Wang G; Zhan Y; Wang H; Li W
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):799-805. PubMed ID: 22037880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; Vessella B; Zangemeister-Wittke U; Gleave ME
    Mol Cancer Ther; 2005 Nov; 4(11):1689-98. PubMed ID: 16275990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New synthetic flavone derivatives induce apoptosis of hepatocarcinoma cells.
    Liu H; Dong A; Gao C; Tan C; Xie Z; Zu X; Qu L; Jiang Y
    Bioorg Med Chem; 2010 Sep; 18(17):6322-8. PubMed ID: 20674374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53.
    Li Z; Tu M; Han B; Gu Y; Xue X; Sun J; Ge Q; Miao Y; Qian Z; Gao W
    PLoS One; 2014; 9(3):e90358. PubMed ID: 24595063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.
    McAllister SD; Christian RT; Horowitz MP; Garcia A; Desprez PY
    Mol Cancer Ther; 2007 Nov; 6(11):2921-7. PubMed ID: 18025276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells.
    Wang X; Ling MT; Guan XY; Tsao SW; Cheung HW; Lee DT; Wong YC
    Oncogene; 2004 Jan; 23(2):474-82. PubMed ID: 14724576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.
    Ozoren N; Kim K; Burns TF; Dicker DT; Moscioni AD; El-Deiry WS
    Cancer Res; 2000 Nov; 60(22):6259-65. PubMed ID: 11103780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.